Literature DB >> 29252168

Clozapine, elevated heart rate and QTc prolongation.

David D Kim1, Randall F White1, Alasdair M Barr1, William G Honer1, Ric M Procyshyn1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29252168      PMCID： PMC5747540          DOI： 10.1503/jpn.170135

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  10 in total

Review 1.  Drug induced QT prolongation and torsades de pointes.

Authors:  Yee Guan Yap; A John Camm
Journal:  Heart       Date:  2003-11       Impact factor: 5.994

Review 2.  Physical Health and Drug Safety in Individuals with Schizophrenia.

Authors:  Tamara Pringsheim; Martina Kelly; Doug Urness; Michael Teehan; Zahinoor Ismail; David Gardner
Journal:  Can J Psychiatry       Date:  2017-07-18       Impact factor: 4.356

Review 3.  AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology.

Authors:  Pentti M Rautaharju; Borys Surawicz; Leonard S Gettes; James J Bailey; Rory Childers; Barbara J Deal; Anton Gorgels; E William Hancock; Mark Josephson; Paul Kligfield; Jan A Kors; Peter Macfarlane; Jay W Mason; David M Mirvis; Peter Okin; Olle Pahlm; Gerard van Herpen; Galen S Wagner; Hein Wellens
Journal:  J Am Coll Cardiol       Date:  2009-03-17       Impact factor: 24.094

4.  Electrocardiographic abnormalities in patients treated with clozapine.

Authors:  U G Kang; J S Kwon; Y M Ahn; S J Chung; J H Ha; Y J Koo; Y S Kim
Journal:  J Clin Psychiatry       Date:  2000-06       Impact factor: 4.384

Review 5.  Update on the clinical efficacy and side effects of clozapine.

Authors:  A Safferman; J A Lieberman; J M Kane; S Szymanski; B Kinon
Journal:  Schizophr Bull       Date:  1991       Impact factor: 9.306

Review 6.  QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review.

Authors:  Mehrul Hasnain; W Victor R Vieweg
Journal:  CNS Drugs       Date:  2014-10       Impact factor: 5.749

7.  An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study)

Authors:  A Sagie; M G Larson; R J Goldberg; J R Bengtson; D Levy
Journal:  Am J Cardiol       Date:  1992-09-15       Impact factor: 2.778

Review 8.  Cardiovascular side-effects of antipsychotic drugs: the role of the autonomic nervous system.

Authors:  Joanne Y T Leung; Alasdair M Barr; Ric M Procyshyn; William G Honer; Catherine C Y Pang
Journal:  Pharmacol Ther       Date:  2012-04-27       Impact factor: 12.310

9.  Optimal QT interval correction formula in sinus tachycardia for identifying cardiovascular and mortality risk: Findings from the Penn Atrial Fibrillation Free study.

Authors:  Parin J Patel; Yuliya Borovskiy; Anthony Killian; Ralph J Verdino; Andrew E Epstein; David J Callans; Francis E Marchlinski; Rajat Deo
Journal:  Heart Rhythm       Date:  2015-11-10       Impact factor: 6.343

10.  Tachycardia in patients treated with clozapine versus antipsychotic long-acting injections.

Authors:  Björn M Nilsson; Oscar Edström; Leif Lindström; Petter Wernegren; Robert Bodén
Journal:  Int Clin Psychopharmacol       Date:  2017-07       Impact factor: 1.659
  10 in total
  6 in total

Review 1.  Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine.

Authors:  Domenico De Berardis; Gabriella Rapini; Luigi Olivieri; Domenico Di Nicola; Carmine Tomasetti; Alessandro Valchera; Michele Fornaro; Fabio Di Fabio; Giampaolo Perna; Marco Di Nicola; Gianluca Serafini; Alessandro Carano; Maurizio Pompili; Federica Vellante; Laura Orsolini; Giovanni Martinotti; Massimo Di Giannantonio
Journal:  Ther Adv Drug Saf       Date:  2018-02-06

2.  Estimation of cardiac QTc intervals in people prescribed antipsychotics: a comparison of correction factors.

Authors:  Teodora Andric; Karl Winckel; Timothy David Tanzer; Samantha Hollingworth; Lesley Smith; Katherine Isoardi; Olivier Tan; Dan Siskind
Journal:  Ther Adv Psychopharmacol       Date:  2022-06-16

3.  Antipsychotic prescribing patterns on admission to and at discharge from a tertiary care program for treatment-resistant psychosis.

Authors:  Lik Hang N Lee; Ric M Procyshyn; Randall F White; Todd S Woodward; William G Honer; Alasdair M Barr
Journal:  PLoS One       Date:  2018-08-10       Impact factor: 3.240

Review 4.  A Focused Review of the Metabolic Side-Effects of Clozapine.

Authors:  Jessica W Y Yuen; David D Kim; Ric M Procyshyn; William J Panenka; William G Honer; Alasdair M Barr
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-25       Impact factor: 5.555

5.  Antipsychotic Drug-Induced Increases in Peripheral Catecholamines are Associated With Glucose Intolerance.

Authors:  Heidi N Boyda; Michelle Pham; Joyce Huang; Amanzo A Ho; Ric M Procyshyn; Jessica W Y Yuen; William G Honer; Alasdair M Barr
Journal:  Front Pharmacol       Date:  2022-02-15       Impact factor: 5.810

Review 6.  QTc Interval Prolongation with Therapies Used to Treat Patients with Parkinson's Disease Psychosis: A Narrative Review.

Authors:  Yasar Torres-Yaghi; Amelia Carwin; Jacob Carolan; Steven Nakano; Fahd Amjad; Fernando Pagan
Journal:  Neuropsychiatr Dis Treat       Date:  2021-12-24       Impact factor: 2.570
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.